✦ LIBER ✦

ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib

✍ Scribed by Douglas Vivona; Carolina T. Bueno; Luciene T. Lima; Rosario D.C. Hirata; Mario H. Hirata; André D. Luchessi; Maria A. Zanichelli; Carlos S. Chiattone; Elvira M. Guerra-Shinohara

Book ID: 116304914
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 251 KB
Volume: 48
Category: Article
ISSN: 1079-9796
DOI: 10.1016/j.bcmd.2011.11.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trough imatinib plasma levels are associ

Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia

✍ Picard, S.; Titier, K.; Etienne, G.; Teilhet, E.; Ducint, D.; Bernard, M.-A.; La 📂 Article 📅 2006 🏛 American Society of Hematology 🌐 English ⚖ 81 KB

Delayed cytogenetic and major molecular

Delayed cytogenetic and major molecular responses associated to increased BMI at baseline in chronic myeloid leukemia patients treated with imatinib

✍ Breccia, Massimo; Loglisci, Giuseppina; Salaroli, Adriano; Serrao, Alessandra; M 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Dasatinib-associated major molecular res

Dasatinib-associated major molecular responses in patients with chronic myeloid leukemia in chronic phase following imatinib failure: response dynamics and predictive value

✍ Hochhaus, A; Müller, M C; Radich, J; Branford, S; Kantarjian, H M; Hanfstein, B; 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 255 KB

Association of genotypes and haplotypes

Association of genotypes and haplotypes of multi-drug transporter genes ABCB1 and ABCG2 with clinical response to imatinib mesylate in chronic myeloid leukemia patients

✍ Au, Anthony; Aziz Baba, Abdul; Goh, Ai Sim; Wahid Fadilah, S. Abdul; Teh, Alan; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 763 KB

Functional polymorphism of CYP2B6 G15631

Functional polymorphism of CYP2B6 G15631T is associated with hematologic and cytogenetic response in chronic myeloid leukemia patients treated with imatinib

✍ Kassogue, Yaya; Quachouh, Meryem; Dehbi, Hind; Quessar, Asma; Benchekroun, Said; 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 282 KB

Durable responses in chronic myeloid leu

Durable responses in chronic myeloid leukemia patients maintained with lower doses of imatinib mesylate after achieving molecular remission

✍ Angelo Michele Carella; Enrica Lerma 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 88 KB